Price T Rowe Associates Inc Avanos Medical, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 65,225 shares of AVNS stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,225
Previous 64,636 0.91%
Holding current value
$1.04 Million
Previous $1.29 Million 21.74%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$19.21 - $24.69 $11,314 - $14,542
589 Added 0.91%
65,225 $1.57 Million
Q2 2024

Aug 14, 2024
BUY
$17.85 - $20.42 $66,723 - $76,329
3,738 Added 6.14%
64,636 $1.29 Million
Q1 2024

May 15, 2024
SELL
$17.97 - $22.68 $3,450 - $4,354
-192 Reduced 0.31%
60,898 $1.21 Million
Q4 2023

Feb 14, 2024
BUY
$17.64 - $22.99 $45,528 - $59,337
2,581 Added 4.41%
61,090 $1.37 Million
Q3 2023

Nov 14, 2023
SELL
$19.93 - $26.31 $429,650 - $567,190
-21,558 Reduced 26.92%
58,509 $1.18 Million
Q2 2023

Aug 14, 2023
SELL
$22.53 - $30.98 $791,546 - $1.09 Million
-35,133 Reduced 30.5%
80,067 $2.05 Million
Q1 2023

May 15, 2023
SELL
$26.92 - $31.75 $301,530 - $355,631
-11,201 Reduced 8.86%
115,200 $3.43 Million
Q4 2022

Feb 14, 2023
SELL
$19.88 - $27.37 $13,041 - $17,954
-656 Reduced 0.52%
126,401 $3.42 Million
Q3 2022

Nov 14, 2022
SELL
$21.56 - $29.59 $208,204 - $285,750
-9,657 Reduced 7.06%
127,057 $2.77 Million
Q2 2022

Aug 15, 2022
BUY
$24.87 - $34.68 $4,327 - $6,034
174 Added 0.13%
136,714 $3.74 Million
Q1 2022

May 16, 2022
BUY
$28.87 - $35.77 $73,907 - $91,571
2,560 Added 1.91%
136,540 $4.57 Million
Q4 2021

Feb 14, 2022
SELL
$29.25 - $36.02 $59.3 Million - $73 Million
-2,027,116 Reduced 93.8%
133,980 $4.65 Million
Q3 2021

Nov 15, 2021
SELL
$31.2 - $38.5 $9.8 Million - $12.1 Million
-314,180 Reduced 12.69%
2,161,096 $67.4 Million
Q2 2021

Aug 16, 2021
SELL
$36.37 - $45.72 $27.1 Million - $34.1 Million
-745,607 Reduced 23.15%
2,475,276 $90 Million
Q1 2021

May 17, 2021
SELL
$43.5 - $53.4 $11.9 Million - $14.6 Million
-273,699 Reduced 7.83%
3,220,883 $141 Million
Q4 2020

Feb 16, 2021
BUY
$33.15 - $49.5 $116 Million - $173 Million
3,494,582 New
3,494,582 $160 Million

Others Institutions Holding AVNS

# of Institutions
274
Shares Held
42.2M
Call Options Held
5.4K
Put Options Held
5K
View Full List

About AVANOS MEDICAL, INC.

AVNS Quotes by TradingView
  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $745M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email